Should You Invest in Cassava Sciences Inc (SAVA) Now?
The 36-month beta value for SAVA is at -0.94. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
The 36-month beta value for SAVA is at -0.94. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0
Cassava Sciences Inc (NASDAQ: SAVA) has experienced a decline in its stock price by -2.40 compared to its previous closing price of 2.50. However, the
The stock price of Cassava Sciences Inc (NASDAQ: SAVA) has jumped by 8.53 compared to previous close of 2.35. Despite this, the company has seen
The stock has a 36-month beta value of -1.08. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as
Cassava Sciences Inc. (SAVA) grew significantly in the past year. A Phase II study of a new Alzheimer’s treatment received a positive response from investors.
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.